Methylprednisolone-induced Acute Pancreatitis, a Case Presentation.

Discov Med

Department of Medicine and Specialty Care Service, Louis A. Johnson VA Medical Center, Clarksburg, WV 26301, USA.

Published: October 2022

Acute pancreatitis is one of the leading gastrointestinal causes of hospitalization in the United States, with drug-induced acute pancreatitis being rare which is only about 0.1-2% of all acute pancreatitis cases (Balani and Grendell, 2008). Based on current publications, there are about 100 medications that can potentially cause drug-induced acute pancreatitis. In this article, we present a case of a 74-year-old man who had been treated with high doses of methylprednisolone for three days prior to the presentation of symptoms in accordance with those of acute pancreatitis. A detailed evaluation of the patient's medical history and exclusion of other probable etiologies confirmed the diagnosis of methylprednisolone-induced pancreatitis. The treatment is supportive care and withdrawal of the offending agent. The diagnosis of drug-induced pancreatitis remains a challenge for clinicians. This case may add further evidence for the role of methylprednisolone in drug-induced acute pancreatitis. It also serves as a reminder to look closely at the patient's history and medications when a cause for acute pancreatitis is not immediately found.

Download full-text PDF

Source

Publication Analysis

Top Keywords

acute pancreatitis
32
drug-induced acute
12
pancreatitis
10
acute
7
methylprednisolone-induced acute
4
pancreatitis case
4
case presentation
4
presentation acute
4
pancreatitis leading
4
leading gastrointestinal
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!